Micromet (NASDAQ: MITI), Monsanto Co. (NYSE: MON), Optimer Pharmaceuticals (NASDAQ: OPTR), Integrated Device Technology, Inc. (NASDAQ: IDTI), InterMune, Inc. (NASDAQ: ITMN) and Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had ratings on them reiterated by analysts.
Micromet (MITI) had its “Buy” rating reiterated by Needham & Company.
Monsanto Co. (MON) had its “Hold” rating reiterated by Jefferies Group (NYSE:JEF).
Optimer Pharmaceuticals (OPTR) had its “Buy” rating reiterated by Needham & Company.
Integrated Device Technology, Inc. (IDTI) had its “Buy” rating reiterated by Canaccord Genuity.
InterMune, Inc. (ITMN) had its “Neutral” rating reiterated by Goldman Sachs (NYSE:GS).
Lexicon Pharmaceuticals, Inc. (LXRX) had its “Buy” rating reiterated by Needham & Company.
No comments:
Post a Comment